Liz Ann Sonders: 2000-Style Market Sell-Off Not a High Risk
Charles Schwab's chief investment strategist discusses the rotation away from COVID-19 'thrivers' and the case for non-U.S. stocks.
Name
|
Value
|
Graph
|
Change
|
Change %
|
---|---|---|---|---|
U.S. Market | Closed | 9,660.63 |
75.47
|
−0.78%
|
U.S. Mid Cap | Closed | 13,059.82 |
110.97
|
−0.84%
|
U.S. Small Cap | Closed | 12,747.25 |
175.80
|
−1.36%
|
DJIA | Closed | 30,814.26 |
177.26
|
−0.57%
|
S&P 500 | Closed | 3,768.25 |
27.29
|
−0.72%
|
NASDAQ | Closed | 12,998.50 |
114.14
|
−0.87%
|
Equity Name
|
Price Change
|
Percent Change
|
---|---|---|
Bionano Genomics Inc |
1.47
|
21.08%
|
Churchill Capital Corp IV Ordinary Shares - Class A |
1.06
|
6.13%
|
BlackBerry Ltd |
0.74
|
8.13%
|
NIO Inc ADR |
4.61
|
−7.57%
|
Apple Inc |
1.77
|
−1.37%
|
Ford Motor Co |
0.34
|
−3.34%
|
Tilray Inc |
1.14
|
6.14%
|
Palantir Technologies Inc Ordinary Shares - Class A |
0.74
|
2.97%
|
Wells Fargo & Co |
2.72
|
−7.83%
|
Plug Power Inc |
6.40
|
−9.62%
|